Home / People / Dr. Eva Graske
Portrait ofEva Graske

Dr. Eva Graske

Counsel
Rechtsanwältin

CMS Hasche Sigle
Stadthausbrücke 1-3
20355 Hamburg
Germany
Languages German, English

Eva Graske advises and represents life sciences companies, with a focus on the pharmaceutical, medical device and biotechnology sector. She specialises in unfair competition and healthcare advertising law, product liability and pharmaceutical law. Eva also advises her clients on R&D, cooperation and distribution agreements as well as on healthcare compliance.

Eva joined CMS in 2014. In 2017, she was seconded to the German subsidiary of an internationally operating US pharmaceutical company. She has been a counsel since 2020.

more less

Publications

  • Patenthinterhalte in Normungsprozessen, Möglichkeiten und Grenzen wettbewerbsrechtlicher Instrumente in vergleichender Untersuchung des US-amerikanischen, europäischen und deutschen Rechts, Mohr Siebeck 2016
more less

Education

  • 2015: PhD (Dr. iur.)
  • 2013: Second state examination in law
  • 2011 - 2013: Trainee lawyer in Hamburg, including placement at Beiersdorf AG
  • 2010: Visiting researcher at Chicago-Kent College of Law
  • 2008: First state examination in law
  • 2003-2008: Law studies in Osnabrueck and Lausanne
more less

Feed

15/09/2022
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? The advertising of medicines and medical devices is governed by the Law on Advertising in the Health Sector (Heilmit­tel­wer­bege­setz...
05/10/2020
CMS advises Chart Industries on the sale of its cryobiological products...
Stuttgart - NASDAQ-listed Chart Industries, Inc. has sold its cryobiology business (MVE Biological Products) to Cryoport, Inc. for USD 320 million.A CMS team led by Lead Partner Dr. Tobias Grau provided...
20/03/2015
CMS advises Mani on the acquisition of Schütz Group
Frankfurt/Main – Mani, Inc., the Tokyo Stock Exchange-listed producer of medical devices, has agreed to acquire Schütz Dental GmbH and GDF Gesellschaft für dentale Forschung und Innovationen GmbH...